Committee Vote Unanimous For Higher Reimbursement Rates
Today, members of the Legislature’s Health and Human Services committee voted unanimously in support of a bill to increase reimbursement rates for substance abuse treatment providers.
“Methadone treatment is heavily researched and evidence based. It gets people back on their feet, back to their families, and back to work,” said Speaker Eves (D-North Berwick). “Providing more sufficient reimbursement to methadone providers will enable more Mainers to access life-saving treatment and regain their lives.”
LD 1473 “Resolve to Increase Access to Opiate Addiction Treatment in Maine” sponsored by Senator Woodsome (R-York) passed as amended.
The report of the HHS Committee partially restores the MaineCare reimbursement rate paid to outpatient opioid treatment providers from $60 to $72 a week. The rate increase will sunset on June 30, 2017 pending a rate study to further analyze its effectiveness. The committee will then hear a report back by the end of December in that year.
This proposal will lower the burden on treatment providers who will then be able to increase patient access and provide crucial individual and group counseling in addition to critical medication, including methadone.
“This session alone, we have heard dozens of hours of testimony urging us to increase availability of drug treatment and support services,” said HHS House Chair Rep. Drew Gattine (D-Westbrook). “Increased access to proven Methadone treatment will provide a vital tool to addressing the opioid crisis that has gripped our state.”
LD 1473 now faces action in both the House and Senate.